Biofrontera implements new Falsified Medicines Directive
11 févr. 2019 10h02 HE
|
Biofrontera AG
Leverkusen, Germany, Feb. 11, 2019 (GLOBE NEWSWIRE) -- Biofrontera AG (NASDAQ: BFRA; Frankfurt Stock Exchange: B8F) (the “Company”), an international biopharmaceutical company, has implemented all...